Literature DB >> 29385580

Patient communication of cancer genetic test results in a diverse population.

Charité N Ricker1, Rachel B Koff2, Chenxu Qu1, Julie Culver1, Duveen Sturgeon1, Kerry E Kingham2, Katrina Lowstuter1, Nicolette M Chun2, Courtney Rowe-Teeter2, Alexandra Lebensohn2, Peter Levonian2, Katlyn Partynski1, Karlena Lara-Otero2, Christine Hong1, Iva M Petrovchich2, Meredith A Mills2, Anne-Renee Hartman3, Brian Allen3, Uri Ladabaum2, Kevin McDonnell1, James M Ford2, Stephen B Gruber1, Allison W Kurian2, Gregory E Idos1.   

Abstract

Research on the communication of genetic test results has focused predominately on non-Hispanic White (NHW) mutation-positive families with high-risk hereditary cancer conditions. Little is known about this process for racially and ethnically diverse individuals or for those with mutations in moderate risk genes. The communication behaviors of study participants who carry a gene mutation were analyzed 3 months after disclosure of genetic test results. Participants were queried about communication of their results, as part of a prospective study of multi-gene panel genetic testing. The responses of particpants who tested positive were analyzed by race/ethnicity and by level of cancer risk (high vs. moderate). Of the 216 mutation-positive study participants, 136 (63%) responded. Self-reported race/ethnicity was 46% NHW, 41% Hispanic, 10% Asian, and 2% Black. The majority (99.0%, n = 135) had shared their results with someone and 96% had told a family member (n = 130). Hispanic respondents were less likely to have told a healthcare provider about their results than NHW (29% vs. 68%, p < .0001). Asian respondents were less likely than NHW to encourage family members to undergo testing (OR = 0.1, p = .03); but Asian family members were more likely to undergo testing (OR = 8.0, p = .03). There were no differences in communication between those with a mutation in a high- or moderate-risk gene. Three months post genetic testing, communication of results was very high; 30% reported a family member underwent genetic testing. Further studies are needed to better understand the communication process in individuals from diverse racial/ethnic backgrounds. © Society of Behavioral Medicine 2018.

Entities:  

Keywords:  Family communication; Hereditary cancer; Multi-gene panels

Mesh:

Year:  2018        PMID: 29385580      PMCID: PMC6065549          DOI: 10.1093/tbm/ibx010

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  49 in total

1.  Communicating genetic test results to the family: a six-step, skills-building strategy.

Authors:  M B Daly; A Barsevick; S M Miller; R Buckman; J Costalas; S Montgomery; R Bingler
Journal:  Fam Community Health       Date:  2001-10

2.  Facilitating family communication about predictive genetic testing: probands' perceptions.

Authors:  Clara L Gaff; Veronica Collins; Tiffany Symes; Jane Halliday
Journal:  J Genet Couns       Date:  2005-04       Impact factor: 2.537

3.  A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.

Authors:  J M Eggington; K R Bowles; K Moyes; S Manley; L Esterling; S Sizemore; E Rosenthal; A Theisen; J Saam; C Arnell; D Pruss; J Bennett; L A Burbidge; B Roa; R J Wenstrup
Journal:  Clin Genet       Date:  2013-12-20       Impact factor: 4.438

4.  Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.

Authors:  Iris van Oostrom; Hanne Meijers-Heijboer; Hugo J Duivenvoorden; Annette H J T Bröcker-Vriends; Christi J van Asperen; Rolf H Sijmons; Caroline Seynaeve; Arthur R Van Gool; Jan G M Klijn; Aad Tibben
Journal:  Patient Educ Couns       Date:  2006-07-26

5.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

6.  Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.

Authors:  Karin Landsbergen; Chris Verhaak; Floor Kraaimaat; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

7.  Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network.

Authors:  C Julian-Reynier; H Sobol; C Sévilla; C Noguès; P Bourret
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

8.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

9.  Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age.

Authors:  Ashley Elrick; Sato Ashida; Jennifer Ivanovich; Sarah Lyons; Barbara B Biesecker; Melody S Goodman; Kimberly A Kaphingst
Journal:  J Genet Couns       Date:  2016-07-16       Impact factor: 2.537

10.  Gene-panel sequencing and the prediction of breast-cancer risk.

Authors:  Douglas F Easton; Paul D P Pharoah; Antonis C Antoniou; Marc Tischkowitz; Sean V Tavtigian; Katherine L Nathanson; Peter Devilee; Alfons Meindl; Fergus J Couch; Melissa Southey; David E Goldgar; D Gareth R Evans; Georgia Chenevix-Trench; Nazneen Rahman; Mark Robson; Susan M Domchek; William D Foulkes
Journal:  N Engl J Med       Date:  2015-05-27       Impact factor: 91.245

View more
  10 in total

1.  The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations.

Authors:  Laura M Amendola; Jonathan S Berg; Carol R Horowitz; Frank Angelo; Jeannette T Bensen; Barbara B Biesecker; Leslie G Biesecker; Gregory M Cooper; Kelly East; Kelly Filipski; Stephanie M Fullerton; Bruce D Gelb; Katrina A B Goddard; Benyam Hailu; Ragan Hart; Kristen Hassmiller-Lich; Galen Joseph; Eimear E Kenny; Barbara A Koenig; Sara Knight; Pui-Yan Kwok; Katie L Lewis; Amy L McGuire; Mary E Norton; Jeffrey Ou; Donald W Parsons; Bradford C Powell; Neil Risch; Mimsie Robinson; Christine Rini; Sarah Scollon; Anne M Slavotinek; David L Veenstra; Melissa P Wasserstein; Benjamin S Wilfond; Lucia A Hindorff; Sharon E Plon; Gail P Jarvik
Journal:  Am J Hum Genet       Date:  2018-09-06       Impact factor: 11.025

2.  Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for translational behavioral medicine research, practice, and policy.

Authors:  Kristi D Graves; Michael J Hall; Kenneth P Tercyak
Journal:  Transl Behav Med       Date:  2018-01-29       Impact factor: 3.046

3.  Psychosocial Effects of Multigene Panel Testing in the Context of Cancer Genomics.

Authors:  Jada G Hamilton; Mark E Robson
Journal:  Hastings Cent Rep       Date:  2019-05       Impact factor: 2.683

Review 4.  Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review.

Authors:  Alison Luk Young; Aalya Imran; Michael J Spoelma; Rachel Williams; Katherine M Tucker; Jane Halliday; Laura E Forrest; Claire E Wakefield; Phyllis N Butow
Journal:  Eur J Hum Genet       Date:  2022-10-17       Impact factor: 5.351

Review 5.  The role of genomics in global cancer prevention.

Authors:  Ophira Ginsburg; Paul Brennan; Patricia Ashton-Prolla; Anna Cantor; Daniela Mariosa
Journal:  Nat Rev Clin Oncol       Date:  2020-09-24       Impact factor: 66.675

6.  Genetic counseling and testing for Asian Americans: a systematic review.

Authors:  Jennifer L Young; Julie Mak; Talia Stanley; Michelle Bass; Mildred K Cho; Holly K Tabor
Journal:  Genet Med       Date:  2021-05-10       Impact factor: 8.822

7.  Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers.

Authors:  Marleah Dean; Ann L Tezak; Sabrina Johnson; Joy K Pierce; Anne Weidner; Kate Clouse; Tuya Pal; Deborah Cragun
Journal:  Patient Educ Couns       Date:  2021-01-05

8.  Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.

Authors:  Jennifer L Caswell-Jin; Anjali D Zimmer; Will Stedden; Kerry E Kingham; Alicia Y Zhou; Allison W Kurian
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

9.  Hereditary cancer panel testing challenges and solutions for the latinx community: costs, access, and variants.

Authors:  Michael P Douglas; Grace A Lin; Julia R Trosman; Kathryn A Phillips
Journal:  J Community Genet       Date:  2021-11-06

10.  IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.

Authors:  Deborah Cragun; Jason Beckstead; Meagan Farmer; Gillian Hooker; Marleah Dean; Ellen Matloff; Sonya Reid; Ann Tezak; Anne Weidner; Jennifer G Whisenant; Tuya Pal
Journal:  BMC Cancer       Date:  2021-10-13       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.